You are here: Industry Insights > Merck

News List

Merck will delay filing Ebola vaccine for approval until 2018, company confirms fiercepharma
November 22, 2017
Despite a frantic effort to rush Ebola vaccines through testing during a deadly epidemic, Merck & Co. will fall short of its goal to file its candidate for FDA approval this year, the company confirmed Tuesday.
Merck subsidiary acquires Teqqa, an infectious disease analytics firm biospectrumasia
November 22, 2017
Teqqa, based in Wyoming, has deep experience working with hospitals to implement disease surveillance solutions and turn lab and medication data into actionable information.
Cue Biopharma announces research collaboration with Merck biospectrumasia
November 20, 2017
Under the terms of the deal, the CUE Biologics™ platform will be leveraged to develop biologics engineered to selectively modulate disease-relevant T cell subsets for the treatment of autoimmune disease
With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial biospace
November 17, 2017
Moderna Therapeutics announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a messenger RNA (mRNA)-based personalized cancer vaccine.
Amgen, Merck, Roche get in on Syapse’s $30M round fiercebiotech
November 16, 2017
Syapse picked up $30 million in series D financing, funds it will use to bring its oncology precision medicine software to more healthcare providers.
Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid U.S. outbreaks fiercepharma
November 15, 2017
Since March, the CDC’s Division of Viral Hepatitis has identified hepatitis A outbreaks in several cities in California, Michigan and Utah, especially among people who are homeless and people who use drugs.
Merck Receives Positive CHMP Opinion for PREVYMIS in the European Union americanpharmaceuticacreview
November 14, 2017
Merck also has filed letermovir for regulatory approval in other markets including Japan, where it is currently under review.
Merck Receives FDA Approval for GONAL-f Prefilled Pen americanpharmaceuticacreview
November 14, 2017
Merck announced that the company received approval for a new version of GONAL-f (follitropin alfa injection) prefilled pen from the U.S.
Heron takes on Merck's Emend with FDA win for antinausea drug Cinvanti fiercepharma
November 13, 2017
Merck’s drug for chemo-induced nausea and vomiting has some new competition.
Merck KGaA's Mavenclad, Roche's Perjeta win 'innovative' coverage deals with NHS fiercepharma
November 13, 2017
Roche has also had issues winning coverage for some of its other new cancer drugs in the U.K., such as Tecentriq and Kadcyla.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page